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Introduction
Renal dysfunction in patients with severe left ventricular
(LV) dysfunction is an independent risk factor for mortal-
ity. Delayed hyperenhancement magnetic resonance
imaging (DHE-MRI) accurately detects myocardial fibro-
sis (scar), seen commonly in this group.
Purpose
We sought to determine the association of myocardial scar
and renal dysfunction on survival in this group.
Methods
We studied 176 consecutive patients (61 ± 13 years, 73%
men) with severe LV systolic dysfunction (mean ejection
fraction (24 ± 8%) who underwent DHE-MRI on 1.5 T MR
scanners (Siemens, Erlangen, Germany) from 2005–6.
DHE-MR images were obtained in standard long and
short axis orientations (covering the entire LV), after injec-
tion of Gadolinium dimenglumine using an inversion
recovery spoiled gradient echo sequence: TE 4 msec, TR 8
msec, flip angle 30°, bandwidth 140 Hz/pixel, 23 k-space
lines acquired every other RR-interval, field of view (var-
ied from 228–330 in the x-direction and 260–330 in the
y-direction) and matrix size (varied from 140–180 in the
x-direction and 256 in the y-direction). For DHE-MRI
analysis, a custom analysis package (VPT software, Sie-
mens, Erlangen, Germany) was used to manually deline-
ate endocardial and epicardial myocardial edges. Scar was
defined as having intensity >2 SD above viable myocar-
dium (identified by a user-specified region of interest).
Glomerular filtration rate (GFR, ml/min/1.73 m2) was
calculated using the following formula: 186 × (serum cre-
atinine-1.154) × (age-0.203) × 1.212 (if black) × 0.742 (if
female). We divided patients into 4 groups: 1) GFR > 60,
no scar (n = 28) 2) GFR > 60 with scar (n = 85) 3) GFR ≤
60, no scar (n = 9) and 4) GFR ≤ 60 with scar (n = 53).
Results
Overall, there were 24 deaths and of these, 14 patients
(65%) had myocardial scar. The incidence of deaths was
highest in group 4 – there were no deaths in group 1, 7 in
group 2, 3 in group 3 and 14 in group 4 (p < 0.001). Mean
GFR was 70 ± 29 and 62 (35%) patients had at-least mod-
erate renal dysfunction (GFR < 60). The frequency of myo-
cardial scar was higher in patients with GFR > 60 vs. those
with GFR ≤ 60 (92% VS. 79%, p = 0.02). On multiple
regression (including GFR, myocardial scar, coronary
artery disease, hypertension, diabetes and coronary
bypass), GFR and myocardial scar were associated with
mortality (both p value < 0.05, overall model p value <
0.001). One year survival was significantly worse for
groups 2, 3 and 4, compared to group 1 (log rank p value
< 0.001).
Conclusion
Renal dysfunction is associated with a higher frequency of
myocardial fibrosis in patients with severe LV dysfunc-
tion. Presence of renal dysfunction, myocardial fibrosis or
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both is associated with worse survival in such patients.
The mechanistic association between renal dysfunction
and myocardial fibrosis needs to be further defined.Page 2 of 2
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